There are currently a limited number of treatment strategies for the treatment of diseases of the central nervous system, including brain injury, stroke, and neurodegenerative diseases. The goal of our work is to learn how to interact with the brain in pathological states and transfer these properties to engineered nanomaterials that are responsive to disease-specific biology.